|
Frequency of identified panel of markers in lobular carcinoma and controls [9] |
||
| Gene/Marker |
Cancer |
Controls |
|
|
||
| BRCA1 |
0.7% (1/140) |
0% (0/140) |
|
|
||
| CHEK2 |
19.4% (27/139) |
4.3% (6/140) |
|
|
||
| p53 |
10.7% (12/112) |
6% (8/134) |
|
|
||
| BRCA2 |
9% (9/100) |
4.8% (9/126) |
|
|
||
| FGFR - nAA |
75.8% (69/91) |
60% (72/120) |
|
|
||
| TNR |
72.7% (16/22) |
39.6% (19/48) |
|
|
||
| NOD2 |
16.7% (1/6) |
0% (0/29) |
|
|
||
| M3K - nAA |
80% (4/5) |
41.4% (12/29) |
|
|
||
| Any marker |
99.30% (139/140) |
87.90% (123/140) |
|
|
||
| Statistic |
P = 0.00073 |
|
Dębniak and Lubiński Hereditary Cancer in Clinical Practice 2008 6:69 doi:10.1186/1897-4287-6-2-69 |
||